A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab.

MLA

Kuba, Kiyomi, et al. “A Retrospective Analysis of Tumor Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma Patients Treated with Nivolumab.” Scientific Reports, vol. 12, no. 1, Dec. 2022, p. 22557. EBSCOhost, https://doi.org/10.1038/s41598-022-27237-0.

APA

Kuba, K., Inoue, H., Matsumura, S., Enoki, Y., Kogashiwa, Y., Ebihara, Y., Nakahira, M., Yamazaki, T., Yasuda, M., Kaira, K., Kagamu, H., & Sugasawa, M. (2022). A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab. Scientific Reports, 12(1), 22557. https://doi.org/10.1038/s41598-022-27237-0

Chicago

Kuba, Kiyomi, Hitoshi Inoue, Satoko Matsumura, Yuichiro Enoki, Yasunao Kogashiwa, Yasuhiro Ebihara, Mitsuhiko Nakahira, et al. 2022. “A Retrospective Analysis of Tumor Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma Patients Treated with Nivolumab.” Scientific Reports 12 (1): 22557. doi:10.1038/s41598-022-27237-0.